(Q38984342)

English

Frequency of VKORC1 (C1173T) and CYP2C9 genetic polymorphisms in Egyptians and their influence on warfarin maintenance dose: proposal for a new dosing regimen

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Frequency of VKORC1 (C1173T) and CYP2C9 genetic polymorphisms in Egyptians and their influence on warfarin maintenance dose: proposal for a new dosing regimen (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1 reference

based on heuristic

inferred from title

author name string

M S El Din

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

D G Amin

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

S B Ragab

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

E E Ashour

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

M H Mohamed

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

A M Mohamed

6

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

publication date

26 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

International Journal of Laboratory Hematology

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

517-524

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Pharmacogenetics of oral anticoagulants

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01426.X

21 January 2018

The pharmacogenetics of CYP2C9 and CYP2C19: ethnic variation and clinical significance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01426.X

21 January 2018

A rapid-ACCE review of CYP2C9 and VKORC1 alleles testing to inform warfarin dosing in adults at elevated risk for thrombotic events to avoid serious bleeding

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01426.X

21 January 2018

Evaluation of genetic factors for warfarin dose prediction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01426.X

21 January 2018

A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01426.X

21 January 2018

A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01426.X

21 January 2018

Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 - rationale and perspectives

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01426.X

21 January 2018

The largest prospective warfarin-treated cohort supports genetic forecasting

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01426.X

21 January 2018

Genetic testing before anticoagulation? A systematic review of pharmacogenetic dosing of warfarin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01426.X

21 January 2018

SYBR Green-based real-time PCR assay for detection of VKORC1 and CYP2C9 polymorphisms that modulate warfarin dose requirement

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01426.X

21 January 2018

Rheumatic fever--is it still a problem?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01426.X

21 January 2018

Genotypes of vitamin K epoxide reductase, gamma-glutamyl carboxylase, and cytochrome P450 2C9 as determinants of daily warfarin dose in Japanese patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01426.X

21 January 2018

Influence of CYP2C9 and VKORC1 1173C/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01426.X

21 January 2018

Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01426.X

21 January 2018

Frequency of CYP2C9 genotypes among Omani patients receiving warfarin and its correlation with warfarin dose.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01426.X

21 January 2018

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01426.X

21 January 2018

Frequency of cytochrome P450 2C9 mutant alleles in a Korean population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01426.X

21 January 2018

Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01426.X

21 January 2018

Oral anticoagulants: Pharmacogenetics Relationship between genetic and non-genetic factors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01426.X

21 January 2018

Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01426.X

21 January 2018

Pharmacogenetics of oral anticoagulants: a basis for dose individualization

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01426.X

21 January 2018

Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01426.X

21 January 2018

Association of Vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01426.X

21 January 2018

Frequency of cytochrome P450 CYP2C9 variants in a Turkish population and functional relevance for phenytoin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01426.X

21 January 2018

The impact of genetic polymorphisms and patient characteristics on warfarin dose requirements: a cross-sectional study in Iran

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01426.X

21 January 2018

CYP2C9*2 and CYP2C9*3 Alleles Confer a Lower Risk for Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01426.X

21 January 2018

Identifiers

10.1111/J.1751-553X.2012.01426.X

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38984342&oldid=1800779082"